SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-156826

Patient #038

Ho Wan Qi · 55y · Female · Chinese · BMI 23.2 · ECOG 0
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Rajesh Kumar
IIIA (T2a, N2a)Disease-free
EGFR L861QTP53
Clinical storyline

Ho Wan Qi, a 55-year-old Chinese female (never, ECOG 0), presented in 2025-03 with shoulder/back pain (suspected pancoast). Workup confirmed Adenocarcinoma (Stage III, EGFR L861Q). The MDT recommended curative-intent surgery. Current status: Disease-free.

HPE Results
Moderately differentiated adenocarcinoma, mainly acinar and partly lepidic, LVI, STATS present, T2a EGFR L861Q positive, TP53 co-mutation
Clinical Stage
IIIA (T2a, N2a)
Pathological Stage
IIIA (T2a, N2a, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
9.9
Tumor (CT/PET)
3.8 cm
PET SUV
8.4
NGS Results
1. EGFR L861Q Missense mutation
2. TP53 mutation